MyPharmacy+

Honeybex Syrup

Manufactured By Trident Pharma

Salt Synonyms

Rs. 65.24

MRP 68.67

(5% OFF)

Includes all taxes

Package SIZE

bottle of 200 ml Syrup

Price may vary depending on the product batch*

100% Authentic
Products

Free
Shipping*

Products
Return Policy

Information about Honeybex Syrup

Uses / Indications:

Introduction:

Honeybex is a polyherbal preparation indictaed for its immune booster properties. Honeybex has antioxidant immunomodulatory anti-inflammatory and anti-microbial properties. Honeybex increases the levels of antibody forming cells thereby improving body?s resistance to infections. Honeybex contains extract of tomato amla chota gokhru ghritkumari giloy nagbala gudhal choti pipal and tej patta. The unique blend of ingredients act synergistically. As Honeybex is a natural preparation it does not have the adverse effects associated with it. Honeybex reduces fever and is also beneficial in respiratory tract infections including tonsilitis bronchitis and laryngitis. Directions of use: Childrens: one teaspoonful twice a day Adults: Two teaspoonful twice a day Use under medical supervision.

Honeybex Syrup

Manufactured By Trident Pharma

Salt Synonyms

Rs. 65.24

MRP 68.67

Includes all taxes

Package SIZE

Available Substitutes

1 Tree Combo Pack of D-Addiction Powder 200gm & D-Addiction+Drops 30ml

Saisir Global Technologies Pvt Ltd

1 Tree Combo Pack of Vigor Max Sachet (8) & Vigor Max Spray (100ml)

Saisir Global Technologies Pvt Ltd

1 Tree Combo Pack of Vigor Max Sachet (8) Vigor Max Spray (100ml) & Vigor Max Pleasure Gel (100ml)

Saisir Global Technologies Pvt Ltd

1 Tree D-Addiction+ Spray

Saisir Global Technologies Pvt Ltd

1 Tree Ganoderma Veg Capsule

Saisir Global Technologies Pvt Ltd

Uses / Indications:

Introduction:

How to use:

Description:

Benefits:

Safety Advise:

If you miss a dose:

Fact Box:

Primary Use:

Common Side Effects:

Alcohol Interaction:

Pregnancy Interaction:

Lactation Interaction:

Driving Interaction:

Kidney Interaction:

Liver Interaction:

Q&A: